• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌缺氧、扩散受限区域中表皮生长因子受体(EGFR)的下调。

Downregulation of EGFR in hypoxic, diffusion-limited areas of squamous cell carcinomas of the head and neck.

作者信息

Mayer Arnulf, Zahnreich Sebastian, Brieger Jürgen, Vaupel Peter, Schmidberger Heinz

机构信息

Department of Radiation Oncology and Radiotherapy, University Medical Center, Mainz 55131, Germany.

Department of Otolaryngology, Head and Neck Surgery, University Medical Center, Mainz 55131, Germany.

出版信息

Br J Cancer. 2016 Nov 22;115(11):1351-1358. doi: 10.1038/bjc.2016.336. Epub 2016 Nov 1.

DOI:10.1038/bjc.2016.336
PMID:27802455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5129814/
Abstract

BACKGROUND

The receptor for the epidermal growth factor (EGFR) is widely considered to be one of the central drivers of oncogenesis in squamous cell carcinomas of the head and neck region (HNSCC). Inhibition of EGFR using monoclonal antibodies is established both in the curative and the palliative setting in this disease. HNSCCs are known to contain abundant hypoxic tissue areas and hypoxia has been shown to be involved in the (down)regulation of EGFR membrane expression.

METHODS

A novel method for multiplex immunofluorescence and single-cell segmentation (via DAPI-stained nuclei) was established, to study the expression of EGFR, the endogenous hypoxia marker CA IX, and intratumoural diffusion distances from microvessels (using CD34 staining) in 58 human HNSCCs and 9 normal/cancer adjacent tissues.

RESULTS

EGFR was found to be significantly downregulated with increasing distance from tumour microvessels, whereas the opposite was true for CA IX. Larger diffusion-limited areas were correlated with higher expression of CA IX.

CONCLUSIONS

The hypoxic tumour microenvironment may have a major role in mediating resistance against anti-EGFR strategies by downregulating EGFR molecules on tumour cells.

摘要

背景

表皮生长因子(EGFR)受体被广泛认为是头颈部鳞状细胞癌(HNSCC)肿瘤发生的主要驱动因素之一。在该疾病的根治性和姑息性治疗中,使用单克隆抗体抑制EGFR已得到确立。已知HNSCC含有大量缺氧组织区域,并且缺氧已被证明与EGFR膜表达的(下调)调节有关。

方法

建立了一种用于多重免疫荧光和单细胞分割(通过DAPI染色的细胞核)的新方法,以研究58例人类HNSCC和9例正常/癌旁组织中EGFR、内源性缺氧标志物CA IX的表达以及肿瘤内微血管的扩散距离(使用CD34染色)。

结果

发现EGFR随着与肿瘤微血管距离的增加而显著下调,而CA IX则相反。更大的扩散受限区域与CA IX的更高表达相关。

结论

缺氧肿瘤微环境可能通过下调肿瘤细胞上的EGFR分子在介导对抗EGFR策略的耐药性方面发挥主要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb2/5129814/bfb4ec0bb4c7/bjc2016336f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb2/5129814/d2e9cfe3d70e/bjc2016336f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb2/5129814/34f85a1d02d1/bjc2016336f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb2/5129814/6786ddb0bfaa/bjc2016336f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb2/5129814/1f688b0bf530/bjc2016336f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb2/5129814/bfb4ec0bb4c7/bjc2016336f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb2/5129814/d2e9cfe3d70e/bjc2016336f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb2/5129814/34f85a1d02d1/bjc2016336f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb2/5129814/6786ddb0bfaa/bjc2016336f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb2/5129814/1f688b0bf530/bjc2016336f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdb2/5129814/bfb4ec0bb4c7/bjc2016336f5.jpg

相似文献

1
Downregulation of EGFR in hypoxic, diffusion-limited areas of squamous cell carcinomas of the head and neck.头颈部鳞状细胞癌缺氧、扩散受限区域中表皮生长因子受体(EGFR)的下调。
Br J Cancer. 2016 Nov 22;115(11):1351-1358. doi: 10.1038/bjc.2016.336. Epub 2016 Nov 1.
2
Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.头颈部鳞状细胞癌中的缺氧、代谢与生长因子信号传导:原发性肿瘤与异种移植肿瘤之间的相关性
Head Neck. 2014 Sep;36(9):1288-95. doi: 10.1002/hed.23446. Epub 2013 Nov 6.
3
The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines.缺氧肿瘤微环境与对表皮生长因子受体(EGFR)抑制剂的耐药性:西妥昔单抗敏感的头颈部鳞状细胞癌细胞系的临床前研究
BMC Res Notes. 2015 Jun 2;8:203. doi: 10.1186/s13104-015-1197-6.
4
Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.碳酸酐酶IX,一种内源性缺氧标志物,在头颈部鳞状细胞癌中的表达及其与缺氧、坏死和微血管密度的关系。
Cancer Res. 2001 Jul 1;61(13):5262-7.
5
Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma.缺氧诱导头颈部鳞状细胞癌中TFE3的表达。
Oncotarget. 2016 Mar 8;7(10):11651-63. doi: 10.18632/oncotarget.7309.
6
Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.喉癌中表皮生长因子受体的表达预测了在随机对照试验中作为加速放疗的附加手段的缺氧修饰的效果。
Eur J Cancer. 2013 Oct;49(15):3202-9. doi: 10.1016/j.ejca.2013.06.024. Epub 2013 Jul 15.
7
Epidermal Growth Factor Receptor (EGFR) and Keratin 5 (K5): Versatile Keyplayers Defining Prognostic and Therapeutic Sub-classes of Head and Neck Squamous Cell Carcinomas.表皮生长因子受体 (EGFR) 和角蛋白 5 (K5):定义头颈部鳞状细胞癌预后和治疗亚类的多功能关键因子。
Cancer Genomics Proteomics. 2016 Jan-Feb;13(1):75-81.
8
Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.肿瘤抑制性miR-1和miR-206对头颈部鳞状细胞癌的双受体(EGFR和c-MET)抑制作用
J Hum Genet. 2017 Jan;62(1):113-121. doi: 10.1038/jhg.2016.47. Epub 2016 May 12.
9
ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.ASCT2(溶质载体家族1成员5)是一种与表皮生长因子受体(EGFR)相关的蛋白质,可被西妥昔单抗共同靶向,使癌细胞对活性氧诱导的凋亡敏感。
Cancer Lett. 2016 Oct 10;381(1):23-30. doi: 10.1016/j.canlet.2016.07.020. Epub 2016 Jul 19.
10
Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.生物或放化疗治疗的头颈部癌症患者组织坏死、缺氧相关标志物的预后价值及其与 HPV 状态的相关性。
Radiother Oncol. 2018 Jan;126(1):116-124. doi: 10.1016/j.radonc.2017.10.007. Epub 2017 Nov 1.

引用本文的文献

1
Tumor-stroma contact ratio - a novel predictive factor for tumor response to chemoradiotherapy in locally advanced oropharyngeal cancer.肿瘤-基质接触率——局部晚期口咽癌对放化疗反应的一种新型预测因子。
Transl Oncol. 2024 Aug;46:102019. doi: 10.1016/j.tranon.2024.102019. Epub 2024 Jun 3.
2
Response to primary chemoradiotherapy of locally advanced oropharyngeal carcinoma is determined by the degree of cytotoxic T cell infiltration within tumor cell aggregates.局部晚期口咽癌原发放化疗的反应取决于肿瘤细胞聚集体中细胞毒性 T 细胞浸润的程度。
Front Immunol. 2023 Apr 28;14:1070203. doi: 10.3389/fimmu.2023.1070203. eCollection 2023.
3

本文引用的文献

1
Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.磷脂酰肌醇 3-激酶/蛋白激酶 B 信号通路作为肿瘤细胞辐射敏感性的关键介质。
Semin Cancer Biol. 2015 Dec;35:180-90. doi: 10.1016/j.semcancer.2015.07.003. Epub 2015 Jul 17.
2
The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines.缺氧肿瘤微环境与对表皮生长因子受体(EGFR)抑制剂的耐药性:西妥昔单抗敏感的头颈部鳞状细胞癌细胞系的临床前研究
BMC Res Notes. 2015 Jun 2;8:203. doi: 10.1186/s13104-015-1197-6.
3
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches.
头颈癌的精准医学:基因组学与临床前研究方法
J Pers Med. 2022 May 24;12(6):854. doi: 10.3390/jpm12060854.
4
MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma.在晚期喉鳞状细胞癌中,MCM-2、Ki-67 和 EGFR 的表达水平下调。
Sci Rep. 2021 Jul 16;11(1):14607. doi: 10.1038/s41598-021-94077-9.
5
Using the R Package Spatstat to Assess Inhibitory Effects of Microregional Hypoxia on the Infiltration of Cancers of the Head and Neck Region by Cytotoxic T Lymphocytes.使用R软件包Spatstat评估微区域缺氧对细胞毒性T淋巴细胞浸润头颈部区域癌症的抑制作用。
Cancers (Basel). 2021 Apr 16;13(8):1924. doi: 10.3390/cancers13081924.
6
Oxygen Deprivation Modulates EGFR and PD-L1 in Squamous Cell Carcinomas of the Head and Neck.缺氧调节头颈部鳞状细胞癌中的表皮生长因子受体(EGFR)和程序性死亡受体配体1(PD-L1)
Front Oncol. 2021 Feb 26;11:623964. doi: 10.3389/fonc.2021.623964. eCollection 2021.
7
Role of Hypoxia and the Adenosine System in Immune Evasion and Prognosis of Patients with Brain Metastases of Melanoma: A Multiplex Whole Slide Immunofluorescence Study.缺氧和腺苷系统在黑色素瘤脑转移患者免疫逃逸及预后中的作用:一项多重全切片免疫荧光研究
Cancers (Basel). 2020 Dec 13;12(12):3753. doi: 10.3390/cancers12123753.
8
Association of Carbonic Anhydrase 9 Polymorphism and the Epithelial Growth Factor Receptor Mutations in Lung Adenocarcinoma Patients.肺腺癌患者碳酸酐酶9多态性与表皮生长因子受体突变的相关性
Diagnostics (Basel). 2020 Apr 29;10(5):266. doi: 10.3390/diagnostics10050266.
9
Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis.靶向细胞代谢可调节头颈部肿瘤发生。
Int J Mol Sci. 2019 Aug 14;20(16):3960. doi: 10.3390/ijms20163960.
10
Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell Carcinoma.在人头颈部鳞状细胞癌异种移植模型中评估对表皮生长因子受体(EGFR)靶向治疗获得性耐药的成像生物标志物
Front Oncol. 2018 Jul 23;8:271. doi: 10.3389/fonc.2018.00271. eCollection 2018.
头颈部鳞状细胞癌的综合基因组特征分析
Nature. 2015 Jan 29;517(7536):576-82. doi: 10.1038/nature14129.
4
Proteomics. Tissue-based map of the human proteome.蛋白质组学。人类蛋白质组组织图谱。
Science. 2015 Jan 23;347(6220):1260419. doi: 10.1126/science.1260419.
5
PHD3 regulates EGFR internalization and signalling in tumours.PHD3 调节肿瘤中的 EGFR 内化和信号转导。
Nat Commun. 2014 Nov 25;5:5577. doi: 10.1038/ncomms6577.
6
Hypoxia in tumors: pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implications.肿瘤缺氧:发病机制相关分类、缺氧亚型的特征及相关生物学和临床意义。
Adv Exp Med Biol. 2014;812:19-24. doi: 10.1007/978-1-4939-0620-8_3.
7
ScientiFig: a tool to build publication-ready scientific figures.ScientiFig:一款用于创建可直接用于发表的科学图表的工具。
Nat Methods. 2013 Nov;10(11):1048. doi: 10.1038/nmeth.2692.
8
Prognostic role of epidermal growth factor receptor in head and neck cancer: a meta-analysis.表皮生长因子受体在头颈部癌症中的预后作用:一项荟萃分析。
J Surg Oncol. 2013 Nov;108(6):387-97. doi: 10.1002/jso.23406. Epub 2013 Sep 13.
9
Quick-and-clean article figures with FigureJ.使用 FigureJ 快速整洁地制作文章图表。
J Microsc. 2013 Oct;252(1):89-91. doi: 10.1111/jmi.12069. Epub 2013 Jul 26.
10
Molecular pathways in head and neck cancer: EGFR, PI3K, and more.头颈癌中的分子通路:表皮生长因子受体、磷脂酰肌醇-3-激酶等等。
Am Soc Clin Oncol Educ Book. 2013:246-55. doi: 10.14694/EdBook_AM.2013.33.246.